New Two-Drug combo tested for Kids' brain tumors
NCT ID NCT06666348
Summary
This study is testing a new combination of two drugs, mirdametinib (taken by mouth) and vinblastine (given by IV), for children and young adults with a specific type of slow-growing brain tumor. The main goals are to find the safest dose of the drug combination and to see how well it works at shrinking or controlling these tumors. Participants will take the drugs for about a year and then be followed for three more years to monitor their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC LOW-GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Sainte-Justine
RECRUITINGMontreal, Quebec, H3T 1C5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Hospital, London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Childrens and Womens Health Centre of British Columbia - British Columbia Childrens Hospital
RECRUITINGVancouver, British Columbia, V6H 3V4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Stollery Children's Hospital
RECRUITINGEdmonton, Alberta, T6G 2E1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Hospital for Sick Children
RECRUITINGToronto, Ontario, M5G 1E8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.